RAPT Therapeutics, Inc. Operating Lease Right-of-Use Assets
RAPT Therapeutics, Inc. had Operating Lease Right-of-Use Assets of $1.88 million as of 2025-09-30, per its 10-Q filed 2025-11-06.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2025-11-06
- 2025-09-30: Operating Lease, Right-of-Use Asset $1.88M.
- 2025-06-30: Operating Lease, Right-of-Use Asset $2.31M.
- 2025-03-31: Operating Lease, Right-of-Use Asset $2.83M.
- 2024-12-31: Operating Lease, Right-of-Use Asset $3.33M.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2025-09-30 | $1.88M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $2.31M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $2.83M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $3.33M 10-Q · filed 2025-11-06 |
| 2024-09-30 | $3.83M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $4.30M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $4.77M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $5.23M 10-K · filed 2025-03-06 |
| 2023-09-30 | $5.67M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $6.10M 10-Q · filed 2023-08-11 |
| 2023-03-31 | $6.53M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $6.94M 10-K · filed 2024-03-07 |
| 2022-09-30 | $5.78M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $6.05M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $6.32M 10-Q · filed 2022-05-11 |